Patterns of care in the management of high-risk COPD in Australia (2015–2019): an observational study for the CONQUEST quality improvement program

This study was conducted by Optimum Patient Care Australia Pty Ltd (OPCA) and was partially funded by OPCA and AstraZeneca Pty Ltd. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Western Pacific
Published
2025-05-01
DOI
https://doi.org/10.1016/j.lanwpc.2025.101555
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patterns of care in the management of high-risk COPD in Australia (2015–2019): an observational study for the CONQUEST quality improvement program

Russell Wiseman, Sinthia Bosnic‐Anticevich, Kanchanamala Ranasinghe, Marije van Melle et al.
The Lancet Regional Health - Western Pacific
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Patterns of care in the management of high-risk COPD in Australia (2015–2019): an observational study for the CONQUEST quality improvement program

Russell Wiseman, Sinthia Bosnic‐Anticevich, Kanchanamala Ranasinghe, Marije van Melle, Christine Jenkins, David Price, Florian Heraud, Lê Thanh Thảo, Rachel Pullen, Joan B. Soriano, Victoria Carter, Vanessa M. McDonald, Alexander Evans, Paul Leong, Andy Dickens, Alexander Roussos, Jennifer L. Perret, Belinda Cochrane, Chantal Le Lievre, John Blakey, Angelina Catanzariti, Clare Ghisla, Kerry Hancock, Mark Hew, Anita Sharma, Brian Ko, Chi Ming Lau, Porsche Le Cheng, Deb Stewart
article en

Abstract

This study was conducted by Optimum Patient Care Australia Pty Ltd (OPCA) and was partially funded by OPCA and AstraZeneca Pty Ltd. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution.

The Lancet Regional Health - Western PacificVol. 58
Griffith University (AU), Camden and Campbelltown Hospitals (AU), University of Tasmania (AU), The University of Melbourne (AU), Curtin University (AU), Wesley Hospital (AU), Woolcock Institute of Medical Research (AU), Instituto de Salud Carlos III (ES), Box Hill Institute (AU), Sir Charles Gairdner Hospital (AU), Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES), Novo Nordisk (United States) (US), AstraZeneca (Australia) (AU), The George Institute for Global Health (AU), Monash Health (AU), Atrium Medical (Australia) (AU), Nationaal ICT Instituut in de Zorg (NL), Optimum Therapeutics (United States) (US), Melbourne Health (AU), Alfred Health (AU), Universitat de les Illes Balears (ES), Monash University (AU), Western Sydney University (AU), University of Newcastle Australia (AU), Macquarie University (AU)
AstraZeneca, AstraZeneca Australia
Openalex Percentile: Top 85%
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.